Datavault AI Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Datavault AI Inc. (DVLT) on April 23, 2026. The report discloses a material definitive agreement entered into on April 16, 2026, and the subsequent filing of a prospectus supplement to register shares issued in connection with this transaction.
Key Financial Metrics and Transaction Details
The filing details a strategic investment rather than standard operating financial results. Key transaction metrics include:
- Investment Amount: $50 million aggregate consideration.
- Target Acquisition: 8,163,265 shares of Vivasor, Inc. Series A Common Stock.
- Price Per Share: $6.125 per Vivasor share.
- Payment Method: Entirely non-cash consideration via the issuance of 75,942,666 shares of Datavault AI Inc. common stock.
The filing text does not provide current period revenue, profit, cash flow, margins, debt, or liquidity metrics for Datavault AI Inc.
Material Changes
The primary material change is the entry into a Subscription Agreement with Vivasor, Inc., resulting in Datavault AI acquiring a significant equity stake in Vivasor. This transaction involves a substantial issuance of new Datavault shares (75,942,666), which will increase the company's outstanding share count and dilute existing shareholders.
Outlook, Risks, and Management Commentary
Management has executed a strategic investment to acquire equity in Vivasor, Inc. The company filed a prospectus supplement under an effective shelf registration statement (File No. 333-294502) to register the Datavault shares issued for this transaction. The filing includes a legal opinion from Paul Hastings LLP regarding the legality of the share registration. No specific forward-looking guidance, risk factors, or contingencies beyond the standard transaction disclosures are provided in this excerpt.
Key Facts for Investor Verification
- Verify the exact number of Datavault shares outstanding prior to this issuance to calculate the dilution impact of the 75,942,666 new shares.
- Review the full text of the Subscription Agreement (Exhibit 10.1) for any covenants, vesting schedules, or rights associated with the Vivasor shares.
- Confirm the strategic rationale for the investment in Vivasor, Inc., as the filing does not detail the operational synergy or expected return on investment.
- Check the effective shelf registration statement (File No. 333-294502) for any other pending issuances that may impact capital structure.